Research News

BRCA Mutations Confer Risk, Even in Absence of Family History

(October 15, 2015)  According to a Japanese study published in Cancer, BRCA1/2 gene mutations may be associated with an inherited risk of ovarian cancer regardless of family history…

Read on

Most Women Getting BRCA Test not Getting Genetic Counseling

(October 7, 2015) A report published in JAMA Oncology shows that most commercially insured women who underwent BRCA genetic testing did not receive genetic counseling by trained genetics professionals…

Read on

Hormone Replacement Therapy Beneficial to Ovarian Cancer Patients

(October 1, 2015) A new study published in the Journal of Clinical Oncology shows that women with the most common type of ovarian cancer can safely take hormone replacement therapy (HRT), and it could have a beneficial effect on their survival…

Read on

Ovarian Cancer Endpoints at FDA

By Annie Ellis:  On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the…

Read on

Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA)

By Annie Ellis On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the Food…

Read on

Small Trial Shows Promising Results for Nivolumab in Ovarian Cancer

(September 21, 2015) A small study found that treatment with the anti-PD-1 immunotherapy nivolumab was able to produce complete responses in patients with advanced platinum-resistant ovarian cancer…

Read on

Q&A with OCRFA Grantee Kris Wood, PhD

Q&A with Kris Wood, PhD Duke University 2015 Liz Tilberis Award   OCRFA: Tell me about yourself. Kris Wood: I grew up in Georgetown, KY, a rural town in the central part of the state…

Read on

Teaming Up Against Ovarian Cancer

Check out this guest post by Alan D. D’Andrea, MD, and Elizabeth M…

Read on

OCRF Research Shows Heart Medication Prolongs Life in Ovarian Cancer Patients

(August 26, 2015) Women with epithelial ovarian cancer who happened to be taking nonselective beta-blockers for hypertension survived longer than those who were not taking the drugs, according to a large multicenter retrospective study…

Read on

Multi-gene Testing for Ovarian Cancer Risk is Clinically Useful

(August 21, 2015) A study published online in JAMA Oncology this month shows that screening women with a suspected risk of hereditary breast or ovarian cancer with a multigene panel (which looks for mutations in many genes), identifies more people…

Read on

RAD51 Mutations Confer Moderate Risk of Ovarian Cancer

(August 19, 2015)  Deleterious mutations in RAD51C and RAD51D genes are associated with increased risk of epithelial ovarian cancer (EOC), according to a study published online Aug. 10 in the Journal of Clinical Oncology…

Read on

OCRF Research Finds Combination Immunotherapy Promising

(August 19, 2015) Whereas chemotherapy kills cancer cells only while it is being administered, immunotherapy can lead to an adaptive immune response that persists long after treatment is ceased…

Read on